D-0069-2020 Class II Terminated
FDA drug recall D-0069-2020 was initiated by KRS Global Biotechnology, Inc on September 12, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated August 19, 2021). Affected quantity: 4450 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- October 9, 2019
- Initiation Date
- September 12, 2019
- Termination Date
- August 19, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4450 syringes
Product Description
LIDOcaine HCl 2% (PF) 100 mg/5 mL (20 mg/mL) 5 mL Fill in a 6 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487NDC 3321678315
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide
Code Information
All lots remaining within expiry.